Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Non Hematologic Cancers × defactinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 2 Mesothelioma, Malignant 2 Phase IB 1 Ovarian Neoplasms 1 Non Hematologic Cancers 1 Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Endometrioid 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01943292 2017-03-09

Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies

Verastem, Inc.

Phase 1 Completed

9 enrolled 7 charts

Non Hematologic Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡